Account
Vivo appoints Posterscope, Laqshya to handle OOH
MUMBAI: Handset maker, Vivo, has appointed Posterscope India and Laqshya Solutions as its out of home agencies.
According to a media report, the size of the account is said to be Rs 150-200 crore.
The new partnership will build on Vivo’s foundation of existing and unique OOH engagement and initiatives.
Vivo India CMO Jerome Chen says, “OOH has been an integral part of our marketing strategy right from the beginning of our journey in India. Through OOH media, we have been able to successfully establish and position Vivo as a premium brand in the Indian smartphone market. As we continue to grow stronger in India, we believe this partnership will enable us to reach out to a larger consumer base, in both a national and regional level.”
Laqshya executive director and CEO Atul Shrivastava mentions, “The 55-pages brief given for this pitch was one of the best in recent times, which inspired a challenge before us to excel on every parameter. Our research and strategy teams worked very hard on every detail and extracted the data and findings, related to TG, congregation points and competition etc. At every stage of the pitch, we could sense and see client’s seriousness on using the OOH media as a strategic media in the market.”
Posterscope Asia Pacific regional director and Posterscope Group South East Asia group MD Haresh Nayak adds, “We’re extremely proud to add such an iconic brand like Vivo to our client roster. Posterscope will create one of its unique offering which enables us to put data at the heart of our decision making, drive speed at a national, local and campaign level, and use our resources efficiently, We look forward to collaborating with the team on creating some industry/category firsts and setting some benchmarks in smartphone advertising.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
